Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Insomnia in adults (Eszopiclone - Insomnia in adults)

Records returned : 10 (on 17 Jul 2025 at 04:00:50). Return to search results for ' Insomnia in adults '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Eszopiclone

Drug:

Eszopiclone

Indication :

Insomnia in adults

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD2

SPC

2. Zolpidem

Drug:

Zolpidem

Indication :

Insomnia in adults

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

10. Zolpidem

Drug:

Zolpidem

Indication :

Insomnia in adults

Status :

See narrative

Formulations :

Oro-dispersible tablets

Restrictions / Comments:

Important

Orodispersible tablets have not been agreed for addition to formulary. Please contact pharmacy for advice.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD2

SPC

3. Zopiclone

Drug:

Zopiclone

Indication :

Insomnia in adults

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

4. Melatonin

Drug:

Melatonin

Indication :

Insomnia in adults

Status :

Green (see narrative)

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Preferred

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically. Circadin is NON-FORMULARY

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Melatonin

Drug:

Melatonin

Indication :

Insomnia in adults

Status :

Green (see narrative)

Formulations :

Immediate release tablets

Restrictions / Comments:

Important

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

If immediate onset of action is required or crushed to aid swallowing

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

6. Melatonin

Drug:

Melatonin

Indication :

Insomnia in adults

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Important

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

8. Melatonin

Drug:

Melatonin

Indication :

Insomnia in adults

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

All formulations of melatonin for adults under 55 without neurodevelopmental disorders were agreed by APC as NON-FORMULARY

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD1

NICE

Off Label

SPC

9. Melatonin

Drug:

Melatonin

Indication :

Insomnia in adults

Status :

Non Formulary

Formulations :

Capsules

Restrictions / Comments:

Important

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Not a cost effective option

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD1

SPC

7. Daridorexant

Drug:

Daridorexant

Indication :

Insomnia in adults

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

On recommendation from specialist sleep clinics (locally at RSFT/QVH) only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC